The largest database of trusted experimental protocols

Clostridium sporogenes

Sourced in United States

Clostridium sporogenes is an anaerobic, spore-forming bacterium. It is commonly used as a biological indicator for sterilization processes.

Automatically generated - may contain errors

5 protocols using clostridium sporogenes

1

Antimicrobial Evaluation of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial activity of compounds was evaluated in vitro on eight bacterial strains (Escherichia coli ATCC 25922 (ATCC = American Type Culture Collection, Manassas, VA, USA), Pseudomonas aeruginosa ATCC 9027, Proteus hauseri ATCC 13315, Klebsiella pneumoniae ATCC 10031, Staphylococcus aureus ATCC 6538, Bacillus subtilis ATCC 6633, Clostridium sporogenes ATCC 19404 and Micrococcus luteus ATCC 10240) and three fungi (Candida albicans ATCC 10231, Saccharomyces cerevisiae ATCC 9763 and Aspergillus brasiliensis ATCC 16404).
+ Open protocol
+ Expand
2

Clostridium Strains Cultivation and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clostridium difficile strain 630 (ATCC® BAA-1382-FZTM), Clostridium difficile strain 4118 (ATCC® BAA-1870TM), Clostridium sporogenes (ATCC® 15579TM), Clostridium clostridioforme (ATCC® 25537TM), Bacteroides thetaiotaomicron (ATCC® 29148TM), Parabacteroides distasonis (ATCC® 8503TM) Prevotella nigrescens (ATCC® 33563TM), and Bacillus subtilis (ATCC® 6051TM) were purchased from ATCC (Manassas, VA, USA). Pseudomonas aeruginosa PAO1 was provided by Dr. Kendra Rumbaugh. Bacteroides fragilis strain CL05T00C42, Bifidobacterium longum strain 44B, Bifidobacterium breve strain EX336960VC19, Lactobacillus reuteri strain CF48-3A, Lactobacillus johnsonii strain 135-1-CHN, and all other C. difficile isolates described in this study were from BEI Resources, NIAID, NIH.
+ Open protocol
+ Expand
3

Microbial Strain Preparation and Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
All microorganisms were obtained from the American Type Culture Collection (ATCC), the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) or the National Collection of Type Cultures (NCTC) and were stocked in calibrated cryotubes at -80°C after growing in broth. We used the following strains: Enterococcus faecalis ATCC 19433, Staphylococcus aureus DSMZ 799, Kocuria rhizophila ATCC 9341, Bacillus subtilis DSMZ 347, Bacillus cereus ATCC 14579, Bacteroides vulgatus ATCC 8482, Clostridium sporogenes ATCC 19404, Pseudomonas aeruginosa DSMZ 1128, Salmonella enterica subsp. enterica NCTC 6676, Escherichia coli DSMZ 1576, Proteus mirabilis ATCC 29906, Candida albicans DSMZ 1386 and Saccharomyces cerevisiae ATCC 7754.
For the micromanipulation of bacterial cells, microorganisms were plated on agar media after thawing the cryotube at room temperature. Aerobic bacteria were plated on TSA (Merck ref. 146004) and incubated 24h at 32.5°C; anaerobic bacteria were plated on Columbia blood agar (COS) (Merck ref. 146559) and incubated under anaerobic conditions (Genbox, Biomérieux ref. 96124) 24h to 48h at 32.5°C; and yeasts were plated on Sabouraud dextrose agar (SDA) (Merck ref. 146028) and incubated 48h to 72h at 22.5°C.
+ Open protocol
+ Expand
4

Microbial Strains for Antimicrobial Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following EP reference strains were acquired from the American Type Culture Collection (ATCC, Manassas, VA USA): Clostridium sporogenes (ATCC 19404), Staphylococcus aureus (ATCC 6538), Candida albicans (ATCC 10231), Pseudomonas aeruginosa (ATCC 9027), Aspergillus brasiliensis (ATCC 16404) and Bacillus subtilis (ATCC 6633). An inoculum solution containing 10–100 colony forming units (cfu) of each microbial strain in 100 µL of sterile physiological solution (0.9% (m/v) NaCl in H2O) was prepared to inoculate the medium samples, whereas 1–10, 0.5–5 and 0.1–1 cfu in 500 µL of sterile physiological solution was prepared for inoculation of the culture broths as growth controls; all inocula were prepared from lyophilised pellets under sterile conditions according to the manufacturer’s instructions.
All inocula were also plated on Tryptone Soy Agar or Sabouraud Chloramphenicol Agar (Biogenetics, Ponte San Nicolò, Italy) (n=5) and incubated at 37°C and 25°C, respectively, for 24–48 hours. The number of cfu was counted, and the actual inoculum concentration was determined for each micro-organism.
+ Open protocol
+ Expand
5

Characterization of Lactobacillus reuteri I5007

Check if the same lab product or an alternative is used in the 5 most similar protocols
L. reuteri I5007 was isolated from the colonic mucosa of healthy weaning piglets and further confirmed through whole-genome sequencing (NCBI ID: 1340495); this strain was found to be chloramphenicol, kanamycin, and streptomycin-resistant. L. reuteri I5007, mutant L. reuteri I5007, L. johnsonii, L. plantarum, L. delbrueckii, and L. rhamnosus GG were cultured in MRS medium (Solarbio Science and Technology Co., Beijing, China) at 37 ℃ for 20 h under anaerobic conditions. Bacterial cells were collected by centrifugation at 12,000 rpm for 15 min. Heat-killed L. reuteri I5007 was prepared by heating at 95 °C for 20 min. No colonies were detected after 48 h of culture at 37 °C after heat treatment. Clostridium sporogenes (ATCC 15579; American Type Culture Collection) was cultured in fluid thioglycolate medium in an anaerobic atmosphere at 37 °C for 24 h. C. rodentium (ATCC 51459; American Type Culture Collection) was inoculated into LB broth and cultured in a shaker overnight at 37 °C. Overnight culture was then centrifuged at 12,000 rpm for 15 min, washed once, and resuspended at 108 CFU/mL in PBS. L. reuteri I5007 was cultured anaerobically with or without tryptophan at 0.01, 0.1, or 1 mM at 37 °C for 20 h prior to measurement of indole derivatives in the supernatant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!